Cargando…
What is the impact of PCSK9 rs505151 and rs11591147 polymorphisms on serum lipids level and cardiovascular risk: a meta-analysis
BACKGROUND: PCSK9 rs505151 and rs11591147 polymorphisms are identified as gain- and loss-of-function mutations, respectively. The effects of these polymorphisms on serum lipid levels and cardiovascular risk remain to be elucidated. METHODS: In this meta-analysis, we explored the association of PCSK9...
Autores principales: | Qiu, Chengfeng, Zeng, Pingyu, Li, Xiaohui, Zhang, Zhen, Pan, Bingjie, Peng, Zhou Y. F., Li, Yapei, Ma, Yeshuo, Leng, Yiping, Chen, Ruifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469167/ https://www.ncbi.nlm.nih.gov/pubmed/28606094 http://dx.doi.org/10.1186/s12944-017-0506-6 |
Ejemplares similares
-
Characterization of LDLR rs5925 and PCSK9 rs505151 genetic variants frequencies in healthy subjects from northern Chile: Influence on plasma lipid levels
por: Rojas, Claudio, et al.
Publicado: (2019) -
The association of the PCSK9 rs562556 polymorphism with serum lipids level: a meta-analysis
por: Chuan, Junlan, et al.
Publicado: (2019) -
Polymorphisms of rs2483205 and rs562556 in the PCSK9 gene are associated with coronary artery disease and cardiovascular risk factors
por: Gai, Min-Tao, et al.
Publicado: (2021) -
Associations of rs823128, rs1572931, and rs823156 polymorphisms with reduced Parkinson’s disease risks
por: Bai, Ye, et al.
Publicado: (2017) -
Association of rs12487066, rs12044852, rs10735781, rs3135388, rs6897932, rs1321172, rs10492972, and rs9657904 Polymorphisms with Multiple Sclerosis in Iranian Population
por: Razavian, Takavar, et al.
Publicado: (2020)